Tag: montelukast sodium market research

  • Global Montelukast Sodium Market Analysis: Size, Drivers, Trends, Opportunities, And Strategies

    Global Montelukast Sodium Market Analysis: Size, Drivers, Trends, Opportunities, And Strategies

    Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!

    What is the Expected Growth Rate of the Montelukast Sodium Market from 2024 to 2033?
    The montelukast sodium market has also experienced strong growth, expected to rise from $3.52 billion in 2023 to $3.86 billion in 2024, at a CAGR of 9.6%. Growth factors include increasing respiratory disorders, an aging population, rising air pollution, heightened awareness and education, and expansion in emerging markets.

    The montelukast sodium market is projected to grow significantly, reaching $5.59 billion by 2028 at a CAGR of 9.7%. Growth is driven by approvals and launches, clinical studies, patent expirations, regulatory changes, and physician prescribing patterns. Key trends include increased generic competition, a shift towards combination therapies, expansion in emerging markets, focus on pediatric use, and digital health solutions.

    Claim Your Free Sample of the Global Montelukast Sodium Market Report Today!
    https://www.thebusinessresearchcompany.com/sample.aspx?id=16123&type=smp

    What Key Factors Are Fueling the Growth of the Montelukast Sodium Market?
    The growing prevalence of asthma is anticipated to drive the montelukast sodium market. Asthma is a chronic respiratory condition characterized by airway inflammation. Its rising prevalence is linked to environmental factors and lifestyle changes. Montelukast sodium helps manage asthma by blocking leukotrienes that cause inflammation. For instance, the National Health Service reported a 149% increase in hospital admissions for asthma in children in England and Wales between 2021 and 2022. Thus, the increasing prevalence of asthma is boosting the montelukast sodium market.

    What Are the Major Segments of the Montelukast Sodium Market?
    1) By Product: Crystal-like, Form-less Or Amorphous
    2) By Dosage Form: Tablets, Oral Solutions
    3) By Application: Bronchospasm, Allergic Coryza, Asthma, Urticaria, Other Applications

    What New Trends Are Transforming the Montelukast Sodium Market?
    Companies in the montelukast sodium market are expanding their product lines with new drugs like fexofenadine hydrochloride. Morepen Laboratories received FDA approval for its generic anti-allergy drug in December 2021, marking a significant milestone in the anti-allergy sector.

    Order Now for Fast Delivery of Your Montelukast Sodium Market Report!
    https://www.thebusinessresearchcompany.com/report/montelukast-sodium-global-market-report

    Which Regions Are Driving Growth in the Montelukast Sodium Market?
    North America was the largest region in the montelukast sodium market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the montelukast sodium market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    The Montelukast Sodium Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the montelukast sodium market, its market share, and analyzes key competitors along with their market positions.

    The Table Of Content For The Montelukast Sodium Market Include

    1. Montelukast Sodium Market Executive Summary
    2. Montelukast Sodium Market Segments
    3. Montelukast Sodium Market Size And Template Market Growth Rate
    4.  Key Montelukast Sodium Market Trends
    5. Major Montelukast Sodium Market Drivers
    ……
    25. Key Mergers And Acquisitions In The Montelukast Sodium Market
    26. Top Montelukast Sodium Companies
    27. Montelukast Sodium Market Opportunities And Strategies
    28. Montelukast Sodium Market, Conclusions And Recommendations
    29. Appendix

    Discover Related Reports by The Business Research Company:
    Sodium Cocoyl Isethionate Global Market Report 2024
    https://www.thebusinessresearchcompany.com/report/sodium-cocoyl-isethionate-global-market-report

    Sodium Reduction Ingredients Global Market Report 2024
    https://www.thebusinessresearchcompany.com/report/sodium-reduction-ingredients-global-market-report

    Sodium Lauryl Ether Sulfate [SLES] Global Market Report 2024
    https://www.thebusinessresearchcompany.com/report/sodium-lauryl-ether-sulfate-sles-global-market-report

    Learn More About The Business Research Company

    The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

    Contact us at:
    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Global Montelukast Sodium Market Overview 2024: Size, Drivers, And Trends

    Global Montelukast Sodium Market Overview 2024: Size, Drivers, And Trends

    The Business Research Company’s global market reports provide comprehensive analysis on the various markets in 27 industries across 60 geographies.

    Market Overview

    • The montelukast sodium market has seen strong growth, increasing from $3.52 billion in 2023 to $3.86 billion in 2024 at a CAGR of 9.6%.
    • Expected to continue growing, the market will reach $5.59 billion in 2028 at a CAGR of 9.7%.
    • Historic growth factors: increasing respiratory disorders, aging population, rising air pollution, growing awareness, and expansion in emerging markets.
    • Future growth drivers: approval and launch of new drugs, clinical studies, patent expiries, regulatory changes, and physician prescribing patterns.

    Rising Prevalence of Asthma

    • Asthma prevalence is a significant driver for the montelukast sodium market.
    • Asthma causes inflammation and constriction of the airways, leading to symptoms like wheezing and breathlessness.
    • Contributing factors: environmental pollution, allergen exposure, genetic predisposition, urbanization, lifestyle changes, and respiratory infections.
    • Montelukast sodium helps manage asthma symptoms by blocking leukotrienes.
    • Example: National Health Service reported a 149% increase in hospital admissions for children with asthma in England and Wales from 2021 to 2022, indicating the growing need for asthma treatments.

    View More On The Montelukast Sodium Market Report 2024 – https://www.thebusinessresearchcompany.com/report/montelukast-sodium-global-market-report

    Key Market Players

    • Major companies: Pfizer Inc., Merck & Co. Inc., Sanofi Aventis SA, Teva Pharmaceuticals USA Inc., Hetero Labs Ltd., Sun Pharma Industries Ltd., Aurobindo Pharma Limited, Cipla Inc., Intas Pharmaceuticals Ltd., Seqens Group, Sanyo Chemical Industries Ltd., Morepen Laboratories, Neuland Laboratories Ltd., Medopharm Private Ltd., BEC Chemicals Pvt. Ltd, Delmar Chemicals Inc., Kimia Biosciences Ltd., Ortin Laboratories Ltd., MSN Laboratories Pvt Ltd., Vamsi Labs Ltd., LGM Pharma LLC, HRV Global Life Sciences, Sigmak Lifesciences, Akums Lifesciences Ltd., Anwita Drugs & Chemicals Pvt Ltd.

    Introduction of New Anti-Allergy Treatments

    • Companies are expanding their portfolios by developing and gaining approval for new drugs, such as fexofenadine hydrochloride.
    • Fexofenadine hydrochloride: a second-generation antihistamine for allergy symptoms and hay fever.
    • Example: In December 2021, Morepen Laboratories received USFDA approval to market generic fexofenadine hydrochloride in the US, enhancing its anti-allergy market position.

    Strategic Acquisitions

    • Example: In April 2023, SK Capital Partners acquired Apotex Pharmaceutical Holdings Inc.
    • This acquisition enhances SK Capital’s presence in the pharmaceutical industry, providing access to Apotex’s global operations, product portfolio, and workforce.

    Market Segmentation

    • By Product: Crystal-like, Form-less Or Amorphous
    • By Dosage Form: Tablets, Oral Solutions
    • By Application: Bronchospasm, Allergic Coryza, Asthma, Urticaria, Other Applications

    Regional Insights

    • North America was the largest market for montelukast sodium in 2023.
    • Asia-Pacific is expected to be the fastest-growing region during the forecast period.

    Conclusion

    • The montelukast sodium market is poised for continued robust growth due to increasing asthma prevalence, strategic acquisitions, new drug introductions, and regional expansion.
    • Companies are well-positioned to capitalize on emerging trends and opportunities in this dynamic market.

    Request A Sample Of The Global Montelukast Sodium Market Report 2024:
    https://www.thebusinessresearchcompany.com/sample_request?id=16123&type=smp